Published in Clin Chem on November 01, 2003
Comparison of parental reports of smoking and residential air nicotine concentrations in children. Occup Environ Med (2006) 1.17
Benzene exposure: an overview of monitoring methods and their findings. Chem Biol Interact (2010) 0.96
A longitudinal study of environmental tobacco smoke exposure in children: parental self reports versus age dependent biomarkers. BMC Public Health (2008) 0.94
Urinary concentrations of bisphenol A in an urban minority birth cohort in New York City, prenatal through age 7 years. Environ Res (2013) 0.89
A comparison of creatinine vs. specific gravity to correct for urinary dilution of cotinine. Biomarkers (2011) 0.86
Health impact assessment of environmental tobacco smoke in European children: sudden infant death syndrome and asthma episodes. Public Health Rep (2010) 0.85
The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population. J Cyst Fibros (2010) 0.84
Estimation of cutoff values of cotinine in urine and saliva for pregnant women in Poland. Biomed Res Int (2013) 0.84
Passive smoking as a risk factor of dry eye in children. J Ophthalmol (2012) 0.82
Relationship between caregivers' smoking at home and urinary levels of cotinine in children. Int J Environ Res Public Health (2014) 0.81
-The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid. Int J Biol Markers (2011) 0.80
Saliva as a matrix for human biomonitoring in occupational and environmental medicine. Int Arch Occup Environ Health (2014) 0.78
Environmental tobacco smoke exposure and children's intelligence at 8-11 years of age. Environ Health Perspect (2014) 0.77
Decline in non-smoking workers' urine cotinine levels after increased smoking regulation in Korea. Ann Occup Environ Med (2015) 0.75
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA (2007) 6.81
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA (2005) 4.64
Understanding the construct of impulsivity and its relationship to alcohol use disorders. Addict Biol (2010) 3.13
Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome. Addict Behav (2005) 2.45
Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry (2009) 2.25
Modeling the effect of alcohol on smoking lapse behavior. Psychopharmacology (Berl) (2006) 1.95
Smoking status as a clinical indicator for alcohol misuse in US adults. Arch Intern Med (2007) 1.92
Translational research in medication development for nicotine dependence. Nat Rev Drug Discov (2007) 1.81
Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial. Psychol Addict Behav (2007) 1.77
Do daily interactive voice response reports of smoking behavior correspond with retrospective reports? Psychol Addict Behav (2005) 1.65
Network support as a prognostic indicator of drinking outcomes: the COMBINE Study. J Stud Alcohol Drugs (2010) 1.60
Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine Tob Res (2008) 1.46
Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol Psychiatry (2007) 1.42
Message framing for smoking cessation: the interaction of risk perceptions and gender. Nicotine Tob Res (2008) 1.42
Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes. Addict Biol (2010) 1.38
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med (2008) 1.34
Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]raclopride. Biol Psychiatry (2010) 1.33
Knowledge and perceived risk of smoking-related conditions: a survey of cigarette smokers. Prev Med (2005) 1.28
A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology (Berl) (2011) 1.27
Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration. Psychopharmacology (Berl) (2007) 1.24
The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology (Berl) (2012) 1.22
Correspondence between Interactive Voice Response (IVR) and Timeline Followback (TLFB) reports of drinking behavior. Addict Behav (2005) 1.21
Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready? Alcohol Clin Exp Res (2010) 1.19
Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence. Drug Alcohol Depend (2008) 1.19
Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci (2004) 1.19
Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale. Psychol Addict Behav (2007) 1.17
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. Drug Alcohol Depend (2009) 1.16
Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res (2014) 1.15
The inclusion of women and minorities in smoking cessation clinical trials: a systematic review. Am J Addict (2009) 1.12
Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug Alcohol Depend (2010) 1.12
Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine Tob Res (2007) 1.10
Characteristics of tobacco-smoking problem gamblers calling a gambling helpline. Am J Addict (2005) 1.08
Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. Drug Alcohol Depend (2010) 1.06
Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary study. Drug Alcohol Depend (2007) 1.05
Targeting cessation: understanding barriers and motivations to quitting among urban adult daily tobacco smokers. Addict Behav (2012) 1.05
A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biol Psychiatry (2003) 1.02
Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol (2012) 1.01
Nicotine and food deprivation decrease the ability to resist smoking. Psychopharmacology (Berl) (2010) 1.01
Gender and weight concerns in adolescent smokers. Addict Behav (2006) 1.00
Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials. Alcohol Clin Exp Res (2014) 0.98
Timing and predictors of postpartum return to smoking in a group of inner-city women: an exploratory pilot study. Birth (2007) 0.97
Consilient research approaches in studying gene x environment interactions in alcohol research. Addict Biol (2010) 0.96
Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence. Biol Psychiatry (2012) 0.95
Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review. Alcohol Alcohol (2007) 0.95
A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain. Addict Behav (2007) 0.94
Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response. Addict Behav (2013) 0.94
Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. J Clin Psychopharmacol (2003) 0.94
The effects of drinking goal on treatment outcome for alcoholism. J Consult Clin Psychol (2012) 0.93
Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology (Berl) (2009) 0.92
Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers. Am J Psychiatry (2013) 0.92
College student receptiveness to various alcohol treatment options. J Am Coll Health (2009) 0.91
A human alcohol self-administration paradigm to model individual differences in impaired control over alcohol use. Exp Clin Psychopharmacol (2013) 0.90
Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients. Alcohol Clin Exp Res (2008) 0.90
Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study. Alcohol Clin Exp Res (2010) 0.90
Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment. Psychol Addict Behav (2009) 0.90
Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler. Int J Neuropsychopharmacol (2010) 0.89
A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers. Drug Alcohol Depend (2009) 0.89
Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans. Pharmacol Biochem Behav (2008) 0.88
Gender effects of reported in utero tobacco exposure on smoking initiation, progression and nicotine dependence in adult offspring. Nicotine Tob Res (2004) 0.88
Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. Drug Alcohol Depend (2010) 0.88
In with the old and out with the new? A comparison of the old and new binge drinking standards. Alcohol Clin Exp Res (2014) 0.88
Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking. Neuropsychopharmacology (2009) 0.87
A pilot study of naltrexone and BASICS for heavy drinking young adults. Addict Behav (2008) 0.87
Tobacco quitlines need to assess and intervene with callers' hazardous drinking. Alcohol Clin Exp Res (2012) 0.87
Transdisciplinary science applied to the evaluation of treatments for tobacco use. Nicotine Tob Res (2003) 0.86
Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence. Neuropharmacology (2011) 0.86
Nicotine dependence and psychiatric and substance use comorbidities in a sample of American Indian male veterans. Drug Alcohol Depend (2008) 0.86
"Quitting smoking will benefit your health": the evolution of clinician messaging to encourage tobacco cessation. Clin Cancer Res (2014) 0.86
Altered hypothalamic response to food in smokers. Am J Clin Nutr (2012) 0.86
Drinking less and drinking smarter: direct and indirect protective strategies in young adults. Psychol Addict Behav (2012) 0.85
Effect of night smoking, sleep disturbance, and their co-occurrence on smoking outcomes. Psychol Addict Behav (2011) 0.85
A brief 7-day estimate of alcohol consumption for use in smoking cessation clinical trials. Addict Behav (2008) 0.84
Does family history of alcoholism moderate naltrexone's effects on alcohol use? J Stud Alcohol Drugs (2011) 0.84
Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial. Biol Psychiatry (2012) 0.84
Relationships between impulsivity and subjective response in an IV ethanol paradigm. Psychopharmacology (Berl) (2014) 0.84
Depressive symptoms, drinking consequences, and motivation to change in first time DWI offenders. Am J Drug Alcohol Abuse (2009) 0.83
Parental history of anxiety and alcohol-use disorders and alcohol expectancies as predictors of alcohol-related problems. J Stud Alcohol Drugs (2009) 0.83
Co-occurring marijuana use is associated with medication nonadherence and nonplanning impulsivity in young adult heavy drinkers. Addict Behav (2011) 0.82
Early subjective response and acquired tolerance as predictors of alcohol use and related problems in a clinical sample. Alcohol Clin Exp Res (2013) 0.82
Beta2* nicotinic acetylcholine receptors modulate pain sensitivity in acutely abstinent tobacco smokers. Nicotine Tob Res (2010) 0.82
Exploring the Utility of Web-Based Social Media Advertising to Recruit Adult Heavy-Drinking Smokers for Treatment. J Med Internet Res (2016) 0.81
Menthol cigarette use predicts treatment outcomes of weight-concerned smokers. Nicotine Tob Res (2013) 0.81
Clinical case discussion: binge eating disorder, obesity and tobacco smoking. J Addict Med (2010) 0.81
N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers. Alcohol Clin Exp Res (2015) 0.81
Preliminary findings on the interactive effects of IV ethanol and IV nicotine on human behavior and cognition: a laboratory study. Nicotine Tob Res (2011) 0.80
Concurrent and predictive validity of drug use and psychiatric diagnosis among first-time DWI offenders. Alcohol Clin Exp Res (2007) 0.79
Sex-specific differences in GABA(A) -benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving. Addict Biol (2012) 0.79
Correspondence of Interactive Voice Response (IVR) reports of nicotine withdrawal, craving, and negative mood with questionnaire ratings. Nicotine Tob Res (2008) 0.79
Transdisciplinary Tobacco Use Research Centers: research achievements and future implications. Nicotine Tob Res (2009) 0.78
A survey of staff attitudes about smoking cessation. Psychiatr Serv (2009) 0.78
A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept. J Clin Psychopharmacol (2014) 0.77
Mediating role of stress reactivity in the effects of prenatal tobacco exposure on childhood mental health outcomes. Nicotine Tob Res (2013) 0.77
Effective Strategies for Maintaining Research Participation in Clinical Trials. Drug Inf J (2009) 0.77
What happens when people discontinue taking medications? Lessons from COMBINE. Addiction (2014) 0.76
From translational neuroscience to personalized medicine. Alcohol Clin Exp Res (2015) 0.75
Internalizing and externalizing dimensions and alcohol use in first time DWI offenders: indirect effects through coping self-efficacy. Psychol Addict Behav (2011) 0.75
Reciprocal Variations in Sleep and Drinking Over Time Among Heavy-Drinking Young Adults. J Abnorm Psychol (2017) 0.75